NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDCR E-015-2002-3-JP-04 MAMMALIAN SWEET AND AMINO ACID HETERODIMERIC TASTE RECEPTORS JP National Stage 2003-510918 Abandoned
NCI E-159-2004-0-US-01 IMMUNE MODULATORY ACTIVITY OF HUMAN RIBONUCLEASES US 60/393,110 Abandoned
NICHD E-225-1997-9-US-01 Methods For The Production Of Purified Recombinant Human Treatment Of Impaired Lung Function & To Enhance Lyphocyte Production US CIP 10/187,498 Abandoned
NCI E-068-2000-0-US-04 Molecules that Influence Pathogen Resistance US National Stage 10/169,315 Abandoned
NIAID E-178-1999-0-US-12 Production Of Attenuated Human-Bovine Chimeric Respiratory Syncytial Virus Vaccines US National Stage 10/030,951 Abandoned
NHLBI E-211-2002-0-US-01 Il-21 Critically Regulates Immunoglobulin Production US 60/393,215 Abandoned
NCI E-069-2001-0-US-02 Use of Lipoxygenase Inhibitors And PPar Ligands as Anti-Cancer Therapeutic And Intervention Agents US ORD 10/186,070 6756399 Abandoned PDF
NCI E-151-2001-0-PCT-02 Method of Promoting Engraftment of a Donor Transplant in a Recipient Host PCT PCT PCT/US02/20550 Abandoned
NCI E-262-2000-1-US-01 SH2 DOMAIN BINDING INHIBITORS US 60/392,028 Abandoned
NINDS E-143-2002-0-US-01 Method of Treating Autoimmune Diseases with Interferon-Beta and IL-2R Antagonist US 60/393,021 Abandoned
NCI E-013-2002-0-US-01 Humanized Anti-Tag 72 CC49 For Diagnosis And Therapy of Human Carcinoma US 60/393,077 Abandoned
NHLBI E-160-2002-0-US-01 Trypotophan as a Functional Replacement for ADP-ribose-arginine in Recombinant Proteins US 60/393,033 Abandoned
NICHD E-013-2000-0-US-06 PROCESS FOR PREPARING 17alpha-ACETOXY-11beta-(4-N,N-(DIMETHYLAMINO) PHENYL)-21-METHOXY-19-NOREGNA-4,9-DIENE-3,20-DIONE,INTERMEDIATES US National Stage 10/169,139 6768014 Expired PDF
NIAID E-115-2000-0-US-12 Attenuated Human-Bovine Chimeric Parainfluenza Virus (PIV) Vaccines US National Stage 10/030,544 Abandoned
NCI E-114-2001-0-PCT-02 Methods of Generating Human CD4+ Th2 Cells PCT PCT PCT/US02/20415 Expired
NCI E-153-1990-1-JP-05 A Non-Mitogenic Competitive HGF Antagonist JP National Stage 2002-186606 Abandoned
NCI E-240-2001-0-PCT-02 Macromolecular Imaging Agents For Liver Imaging PCT PCT PCT/US2002/020118 Expired
NCI E-240-2001-0-EP-03 Macromolecular Imaging Agents For Liver Imaging EP National Stage 02752092.3 Abandoned
NIDDK E-213-2001-2-PCT-01 Vitamin D Receptor Antagonists and Related Compositions and Methods of Use PCT PCT COMB PCT/US02/19774 Expired
NHGRI E-196-2001-0-PCT-02 Use of Interferon-inducible 2',5'-Oligoadenylate-dependent RNase L in The Diagnosis, Prognosis And Treatment of Cancer PCT PCT PCT/US02/19516 Expired
NCI E-059-2001-1-US-01 Transforming Growth Factor Beta(TGF-BETA) Antagonist Selectively Neutralize PATHOLOGICAL TGF BETA. US ORD 10/176,266 Abandoned
NCI E-190-2002-1-US-01 Identification of a Novel BHD Gene US 60/390,291 Abandoned
NCI E-022-1998-0-US-06 ALKENYLDIARYLMETHANE NON-NUCLEOSIDE HIV-1 REVERSE TRANSCRIPTASE INHBIBITORS (NNRTIS) US National Stage 09/581,927 6569897 Abandoned PDF
NCI E-072-1999-0-US-03 Transition Metal Complexes of N ,N',N-Trialkyl-CIS,CIS-1,3,5- Triaminocyclohexane & Related Compositions & Methods of Synthesis... US National Stage 10/049,115 6765104 Abandoned PDF
NCI E-058-2001-0-PCT-02 Human UGRP (Uteroglobin-Related Protein) 1 Promoter And its Use PCT PCT PCT/US02/19456 Expired
NIAID E-122-2001-0-PCT-02 Anti-Arthropod Vector Vaccines,Methods of Selecting and Uses Thereof PCT PCT PCT/US02/19663 Expired
NIAID E-122-2001-0-EP-03 Anti-Arthropod Vector Vaccines, Methods of Selecting and Uses Thereof EP National Stage 02752074.1 Abandoned
NIAID E-122-2001-0-BR-06 Anti-Arthropod Vector Vaccines, Methods of Selecting and Uses Thereof BR National Stage PI0210539-0 Abandoned
NIAID E-122-2001-0-MX-07 Anti-Arthropod Vector Vaccines, Methods of Selecting and Uses Thereof MX National Stage PA/A/2004/00005 Abandoned
NCI E-056-2002-0-US-01 GRAFTING OF A MURINE ANTIBODY ONTO A HUMAN FRAME WORK US 60/390,033 Abandoned
NCI E-076-2003-0-US-01 METHOD OF TREATING ISCHEMIA/REPERFUSION INJURY WITH NITROXYL ANION DONORS US 60/389,757 Abandoned
NIAID E-131-2002-0-JP-11 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NKT CELLS JP DIV 2010-85587 Abandoned
NIAID E-131-2002-0-ES-23 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS ES EP 10184017.1 Abandoned
NIAID E-131-2002-0-IT-26 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS IT EP 10184017.1 Abandoned
NIAID E-131-2002-0-GB-25 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS GB EP 10184017.1 Abandoned
NIAID E-131-2002-0-CH-21 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS CH EP 10184017.1 Abandoned
NIAID E-131-2002-0-FR-24 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS FR EP 10184017.1 Abandoned
NIAID E-131-2002-0-DE-22 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS DE EP 10184017.1 Abandoned
NIAID E-131-2002-0-EP-12 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS EP DIV 10184017.1 Abandoned
NIAID E-131-2002-0-EP-08 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS EP National Stage 02742057.9 Abandoned
NIAID E-131-2002-0-FR-16 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS FR EP 02742057.9 Abandoned
NIAID E-131-2002-0-DE-14 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS DE EP 02742057.9 Abandoned
NIAID E-131-2002-0-IT-18 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS IT EP 02742057.9 Abandoned
NIAID E-131-2002-0-ES-15 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS ES EP 02742057.9 Abandoned
NIAID E-131-2002-0-GB-17 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS GB EP 02742057.9 Abandoned
NIAID E-131-2002-0-CH-13 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS CH EP 02742057.9 Abandoned
NIAID E-131-2002-0-JP-04 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS JP National Stage 2004-515561 Abandoned
NIAID E-131-2002-0-AU-05 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS;mn AU National Stage 2002315115 Abandoned
NIAID E-131-2002-0-ZA-07 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS ZA National Stage 2005/00375 Abandoned
NIAID E-131-2002-0-PCT-01 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS PCT PCT PCT/US2002/018790 Abandoned